HomeSBS • FRA
Stratec SE
€32.80
Jan 27, 11:47:01 PM GMT+1 · EUR · FRA · Disclaimer
StockDE listed security
Previous close
€33.50
Day range
€32.80 - €32.80
Year range
€26.35 - €48.00
Market cap
396.40M EUR
Avg Volume
39.00
P/E ratio
39.83
Dividend yield
1.68%
Primary exchange
ETR
CDP Climate Change Score
C
Market news
Financials
Income Statement
Revenue
Net income
(EUR)Sep 2024Y/Y change
Revenue
57.23M-8.69%
Operating expense
14.30M49.36%
Net income
549.00K-89.26%
Net profit margin
0.96-88.24%
Earnings per share
EBITDA
7.08M-45.92%
Effective tax rate
34.01%
Total assets
Total liabilities
(EUR)Sep 2024Y/Y change
Cash and short-term investments
33.11M65.06%
Total assets
450.84M1.75%
Total liabilities
223.08M2.68%
Total equity
227.76M
Shares outstanding
12.16M
Price to book
1.79
Return on assets
1.24%
Return on capital
1.47%
Net change in cash
(EUR)Sep 2024Y/Y change
Net income
549.00K-89.26%
Cash from operations
8.05M18.80%
Cash from investing
-3.66M90.04%
Cash from financing
-1.86M2.47%
Net change in cash
2.95M109.19%
Free cash flow
-6.18M-303.79%
About
STRATEC SE is a company with worldwide operations that designs and manufactures fully automated analyzer systems for partners in clinical diagnostics and biotechnology - particularly in the field of in-vitro-diagnostics. As a classic original equipment manufacturer supplier, STRATEC produces its systems almost exclusively on behalf of its customers. Alongside the systems themselves, the company also provides sample preparation solutions, system software and integrated laboratory software. STRATEC is also responsible for development documentation, testing, delivery of systems, and the supply of spare parts and complex consumables for diagnostic and medical applications. STRATEC's customers are well known diagnostic companies like DiaSorin, Abbott, SIEMENS, Bio-Rad or Hologic. Wikipedia
Founded
1979
Employees
1,462
Search
Clear search
Close search
Google apps
Main menu